Pfizer

Pfizer Completes Purchase of ReViral

The transaction expands Pfizer’s anti-infective pipeline and reinforces its commitment to developing medicines.

June 10, 2022

ReViral is a London-based biopharmaceutical company specializing in antiviral therapeutics.

April 07, 2022

Velopi offers consultancy and project management training, and some of its clients include Abbott and Pfizer.

February 23, 2022

The acquisition will add specialized design and engineering capabilities to Angstrom.

February 10, 2022

GeneDx providers expertise in rare disease diagnostic and exome sequencing services.

January 18, 2022

Merck is seeking to capitalize on the success of mRNA vaccines, the technology behind the Covid-19 inoculations.

January 06, 2022

Selib will lead CR&R's engagement with external stakeholders including media, government and trade associations.

December 21, 2021

Pfizer plans to speed up clinical development of etrasimod, Arena’s experimental treatment for immuno-inflammatory diseases.

December 13, 2021